S. R. Walsh

Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.

Bjoern Peters, J. Sidney, A. Sette, 2009, Vaccine.

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Allan C. deCamp, A. Perelson, E. Giorgi, 2021, Nature Medicine.

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study

Allan C. deCamp, J. Weiner, M. Nussenzweig, 2019, PloS one.

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.

Stephen J. Thomas, N. Michael, D. Barouch, 2020, The Lancet. Infectious diseases.

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

K. Stevenson, M. Seaman, R. Dolin, 2010, The Journal of infectious diseases.